
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $13.8M | -- | -- | $0.06 | -- |
07/25/2025 | Q2 | $13.3M | -- | -- | $0.05 | -- |
04/29/2025 | Q1 | $12.4M | $12.9M | $0.05 | $0.03 | $0.02 |
01/30/2025 | Q4 | $12.6M | $12.7M | $0.06 | $0.04 | $0.02 |
10/24/2024 | Q3 | $12.2M | $12.8M | $0.07 | $0.04 | $0.03 |
07/25/2024 | Q2 | $12.2M | $12.2M | $0.05 | $0.06 | -$0.01 |
04/25/2024 | Q1 | $11.9M | $9M | -$0.14 | $0.03 | -$0.17 |
01/25/2024 | Q4 | $13.1M | $12.4M | $0.07 | $0.10 | -$0.03 |
10/26/2023 | Q3 | -- | -- | $0.12 | $0.12 | -- |
07/27/2023 | Q2 | -- | -- | $0.13 | $0.13 | -- |
04/27/2023 | Q1 | -- | -- | $0.14 | $0.19 | -$0.05 |
01/26/2023 | Q4 | -- | -- | $0.24 | $0.24 | -- |
11/10/2022 | Q3 | -- | -- | $0.24 | $0.22 | $0.02 |
07/28/2022 | Q2 | -- | -- | $0.21 | $0.18 | $0.03 |
04/28/2022 | Q1 | -- | -- | $0.19 | $0.19 | -- |
01/27/2022 | Q4 | -- | -- | $0.25 | $0.24 | $0.01 |
11/12/2021 | Q3 | -- | -- | $0.29 | $0.20 | $0.09 |
07/29/2021 | Q2 | -- | -- | $0.26 | $0.14 | $0.12 |
04/29/2021 | Q1 | -- | -- | $0.15 | $0.12 | $0.03 |
01/28/2021 | Q4 | -- | -- | $0.18 | $0.15 | $0.03 |
10/29/2020 | Q3 | -- | -- | $0.11 | $0.09 | $0.02 |
07/30/2020 | Q2 | -- | -- | $0.02 | $0.11 | -$0.09 |
05/07/2020 | Q1 | -- | -- | $0.13 | $0.15 | -$0.02 |
01/23/2020 | Q4 | -- | -- | $0.18 | $0.19 | -$0.01 |
10/24/2019 | Q3 | -- | -- | $0.20 | -- | -- |
07/23/2019 | Q2 | -- | -- | $0.18 | -- | -- |
04/30/2019 | Q1 | -- | -- | $0.19 | -- | -- |
01/24/2019 | Q4 | -- | -- | $0.19 | -- | -- |
10/25/2018 | Q3 | -- | -- | $0.19 | -- | -- |
07/24/2018 | Q2 | -- | -- | $0.20 | -- | -- |
04/26/2018 | Q1 | -- | -- | $0.13 | -- | -- |
01/25/2018 | Q4 | -- | -- | $0.07 | -- | -- |
10/26/2017 | Q3 | -- | -- | $0.14 | -- | -- |
07/25/2017 | Q2 | -- | -- | $0.12 | -- | -- |
04/27/2017 | Q1 | -- | -- | $0.09 | -- | -- |
01/26/2017 | Q4 | -- | -- | $0.09 | -- | -- |
10/27/2016 | Q3 | -- | -- | $0.07 | -- | -- |
07/26/2016 | Q2 | -- | -- | $0.08 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.06 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.08 | -- | -- |
10/27/2015 | Q3 | -- | -- | $0.07 | -- | -- |
Riverview Bancorp reported $12.9M worth of top line sales in its most recent quarter.
Riverview Bancorp announced earnings per share of $0.05 which represents a beat of analyst forecast a $0.03 per share.
Riverview Bancorp reported -- that represents -- per share over the last quarter.
Riverview Bancorp's earnings are forecast to grow from $0.23 per share to $0.18 per share next year representing an increase of 4.35%.
Riverview Bancorp's next earnings date is July 25, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.